Private Advisor Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.7M Sell
233,214
-33,032
-12% -$7.11M 0.27% 70
2026
Q1
$57.9M Sell
266,246
-17,848
-6% -$3.96M 0.27% 72
2025
Q4
$64.9M Buy
284,094
+7,711
+3% +$1.76M 0.31% 60
2025
Q3
$64M Sell
276,383
-3,553
-1% -$724K 0.31% 57
2025
Q2
$52M Buy
279,936
+11,042
+4% +$2.05M 0.28% 72
2025
Q1
$56.3M Sell
268,894
-208,443
-44% -$40.5M 0.34% 57
2024
Q4
$84.8M Buy
477,337
+201,178
+73% +$37M 0.48% 33
2024
Q3
$54.6M Sell
276,159
-4,392
-2% -$820K 0.34% 59
2024
Q2
$48M Buy
280,551
+24,896
+10% +$4.12M 0.32% 62
2024
Q1
$46.6M Sell
255,655
-5,649
-2% -$974K 0.33% 63
2023
Q4
$40.5M Sell
261,304
-93
-0% -$13.6K 0.31% 68
2023
Q3
$39M Sell
261,397
-6,623
-2% -$972K 0.35% 60
2023
Q2
$37M Sell
268,020
-6,590
-2% -$966K 0.32% 66
2023
Q1
$43.8M Sell
274,610
-21,720
-7% -$3.32M 0.42% 44
2022
Q4
$10.1M Sell
296,330
-11,404
-4% -$1.75M 0.51% 37
2022
Q3
$41.3M Sell
307,734
-81,871
-21% -$11.7M 0.47% 38
2022
Q2
$59.7M Sell
389,605
-44,140
-10% -$6.74M 0.53% 34
2022
Q1
$70.3M Buy
433,745
+30,356
+8% +$4.41M 0.54% 31
2021
Q4
$54.6M Sell
403,389
-153,113
-28% -$18.1M 0.41% 44
2021
Q3
$60M Buy
556,502
+162,314
+41% +$18.5M 0.38% 54
2021
Q2
$44.4M Buy
394,188
+31,949
+9% +$3.6M 0.39% 46
2021
Q1
$39.2M Buy
362,239
+80,606
+29% +$8.62M 0.37% 50
2020
Q4
$30.2M Buy
281,633
+57,142
+25% +$5.49M 0.31% 62
2020
Q3
$20M Buy
224,491
+321
+0.1% +$30.2K 0.26% 76
2020
Q2
$22M Buy
224,170
+29,503
+15% +$2.6M 0.31% 65
2020
Q1
$14.8M Buy
194,667
+15,369
+9% +$1.31M 0.27% 75
2019
Q4
$15.9M Buy
179,298
+18,857
+12% +$1.57M 0.25% 89
2019
Q3
$12.2M Buy
160,441
+29,856
+23% +$2.05M 0.19% 115
2019
Q2
$9.5M Sell
130,585
-12,242
-9% -$962K 0.17% 133
2019
Q1
$11.5M Sell
142,827
-3
-0% -$245 0.23% 97
2018
Q4
$13.2M Sell
142,830
-6,374
-4% -$561K 0.32% 66
2018
Q3
$14.1M Sell
149,204
-12,446
-8% -$1.18M 0.29% 71
2018
Q2
$15M Buy
161,650
+67,347
+71% +$6.58M 0.25% 29
2018
Q1
$8.93M Buy
94,303
+2,417
+3% +$266K 0.35% 60
2017
Q4
$9.12M Sell
91,886
-67,101
-42% -$6.32M 0.39% 55
2017
Q3
$14.4M Sell
158,987
-4,609
-3% -$351K 0.36% 59
2017
Q2
$11.8M Buy
163,596
+7,920
+5% +$532K 0.32% 71
2017
Q1
$10.1M Buy
155,676
+15,804
+11% +$994K 0.28% 80
2016
Q4
$8.56M Buy
139,872
+23,316
+20% +$1.42M 0.28% 84
2016
Q3
$7.34M Sell
116,556
-18,606
-14% -$1.2M 0.3% 79
2016
Q2
$8.56M Buy
135,162
+25,271
+23% +$1.54M 0.35% 65
2016
Q1
$6.29M Sell
109,891
-858
-0.8% -$47.8K 0.3% 75
2015
Q4
$6.56M Buy
110,749
+11,909
+12% +$686K 0.31% 73
2015
Q3
$5.38M Buy
98,840
+9,704
+11% +$632K 0.3% 75
2015
Q2
$5.98M Buy
89,136
+11,027
+14% +$720K 0.28% 68
2015
Q1
$4.57M Buy
78,109
+8,827
+13% +$533K 0.26% 79
2014
Q4
$4.47M Buy
69,282
+7,580
+12% +$478K 0.29% 79
2014
Q3
$3.56M Buy
61,702
+9,935
+19% +$552K 0.25% 95
2014
Q2
$2.92M Buy
51,767
+12,295
+31% +$645K 0.25% 88
2014
Q1
$2.03M Buy
39,472
+3,098
+9% +$157K 0.21% 108
2013
Q4
$1.92M Buy
+36,374
New +$1.79M 0.21% 103

Other funds holding ABBV

Private Advisor Group's ABBV Position: Q2 2026 in Review

Private Advisor Group reduced its AbbVie (ABBV) stake by 12% in Q2 2026, selling an estimated $7.11M and leaving 233,214 shares worth $58.7M. The position accounts for 0.27% of the portfolio, ranked #70.

Private Advisor Group first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $84.8M in Q4 2024. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Advisor Group held 233,214 shares of AbbVie worth $58.7M as of Q2 2026.
  • Private Advisor Group sold 33,032 AbbVie shares in Q2 2026, an estimated $7.11M.
  • AbbVie made up 0.27% of Private Advisor Group's portfolio in Q2 2026, its #70 holding.
  • Private Advisor Group first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
  • Private Advisor Group's AbbVie position peaked at $84.8M in Q4 2024.
  • 1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.